Trials / Completed
CompletedNCT04082975
Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain
A Randomized, Double-blind, Active Controlled, Parallel, Multicenter, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 421 (actual)
- Sponsor
- NVP Healthcare · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with acute low back pain.
Detailed description
This study is a randomized, double-blind, active-controlled, parallel, phase 3 study to evaluate efficacy and safety of NVP-1203 in patients with acute low back pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NVP-1203 | Oral dose for 7 days |
| DRUG | NVP-1203-R | Oral dose for 7 days |
| DRUG | NVP-1203 placebo | Oral dose for 7 days |
| DRUG | NVP-1203-R placebo | Oral dose for 7 days |
Timeline
- Start date
- 2020-01-15
- Primary completion
- 2021-05-24
- Completion
- 2021-05-31
- First posted
- 2019-09-10
- Last updated
- 2021-06-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04082975. Inclusion in this directory is not an endorsement.